1. Cancer clinical trial eligibility criteria: available therapy in non-curative settings Publication: Silver Spring, MD : Center for Drug Evaluation and Research, July 2022 Subject(s): Clinical Trials as TopicGovernment RegulationNeoplasms -- drug therapyUnited StatesUnited States. Food and Drug Administration
2. Real-time oncology review (RTOR): guidance for industry Publication: Silver Spring, MD : Center for Drug Evaluation and Research, November 2023 Subject(s): Biological ProductsDrug ApprovalDrug IndustryDrugs, InvestigationalGovernment RegulationNeoplasms -- drug therapyUnited States
3. Submitting patient-reported outcome data in cancer clinical trials: guidance for industry : technical specifications document Publication: [Silver Spring, MD] : Center for Drug Evaluation and Research, November 2023 Subject(s): Clinical Trials as TopicDrug DevelopmentDrug IndustryGovernment RegulationNeoplasms -- drug therapyPatient Reported Outcome MeasuresUnited States
